The Soprano trial is looking at whether a type of radiotherapy, called stereotactic radiotherapy, used on its own or with a type of PARP inhibitor called Niraparib can delay the time before the ovarian cancer starts to grow again and require another type of treatment, like chemotherapy. The study will also look at the side effects of the treatments…